Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - EMERGENT GROUP INC/NYex101.htm
EX-31.B - EXHIBIT 31(B) - EMERGENT GROUP INC/NYex31b.htm
EX-31.A - EXHIBIT 31(A) - EMERGENT GROUP INC/NYex31a.htm
EX-99.1 - EXHIBIT 99.1 - EMERGENT GROUP INC/NYex991.htm
EX-32.A - EXHIBIT 31 (A) - EMERGENT GROUP INC/NYex32a.htm
EX-32.B - EXHIBIT 32 (B) - EMERGENT GROUP INC/NYex32b.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.   20549
___________________________________

FORM 10-Q
___________________________________


Quarterly Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
For the Quarterly Period Ended September 30, 2009


Commission File Number:  1-34208
 
EMERGENT GROUP INC.
(Exact name of registrant as specified in its charter)
 
Nevada
 
93-1215401
(State of jurisdiction of Incorporation)
 
(I.R.S. Employer Identification No.)
 
10939 Pendleton Street
Sun Valley, CA 91352
(Address of principal executive offices)

(818) 394-2800
(Registrant’s telephone number)

Not Applicable
 (Former name, address and fiscal year, if changed since last report)
___________________________________

 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý   No  o
 
Indicate by checkmark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the 12 preceding months (or such shorter period that the registrant was required to submit and post such file). Yes [ ]  No [    ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer o
     
Accelerated filer o
 
 Non-accelerated filer o
 
(Do not check if a smaller reporting company)
 
Smaller reporting company ý
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o   No  ý
 
As of November 9, 2009, the registrant had a total of 6,747,220 shares of Common Stock outstanding.
 
 

 
EMERGENT GROUP INC.

FORM 10-Q Quarterly Report

Table of Contents
 
  Page
PART I.  FINANCIAL INFORMATION   
Item 1.
Financial Statements
 
     
 
Condensed Consolidated Balance Sheets as of September 30, 2009 (unaudited) and December 31, 2008
     
 
Condensed Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2009 and 2008 (unaudited)
 
 
 
 
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2009 and 2008 (unaudited)
 
 
 
 
Notes to Condensed Consolidated Financial Statements
6
     
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12
 
 
 
Item 3.
Quantitative and Qualitative Disclosures and Market Risk
17
     
Item 4.
Controls and Procedures
17
     
PART II.  OTHER INFORMATION
 
     
Item 1.
Legal Proceedings
18
     
Item1A.
Risk Factors
18
     
Item 2.
Changes in Securities
18
     
Item 3.
Defaults Upon Senior Securities
18
     
Item 4.
Submissions of Matters to a Vote of Security Holders
18
     
Item 5.
Other Information
18
     
Item 6.
Exhibits
18
     
Signatures
19 

 
 
2


PART I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

Emergent Group Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
             
   
September 30,
   
December 31,
 
   
2009
   
2008
 
ASSETS
 
(Unaudited)
       
             
Current assets
           
     Cash
  $ 5,957,808     $ 4,586,107  
Accounts receivable, net of allowance for doubtful
               
accounts of $80,400 and $58,984
    4,305,605       3,759,834  
Inventory, net
    834,828       837,143  
Prepaid expenses
    321,092       231,763  
Deferred income taxes
    506,923       986,000  
Total current assets
    11,926,256       10,400,847  
                 
Property and equipment, net of accumulated depreciation and
               
amortization of $8,500,276 and $7,247,482
    5,787,670       6,070,228  
Goodwill
    1,120,058       1,120,058  
Deferred income taxes
    522,955       1,261,000  
Other intangible assets, net of accumulated amortization of
               
$276,912 and $226,997
    482,454       403,152  
Deposits and other assets
    81,094       84,934  
                 
Total assets
  $ 19,920,487     $ 19,340,219  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
                 
Current liabilities
               
Current portion of capital lease obligations
  $ 1,911,641     $ 1,909,057  
Dividends payable
    -       1,989,750  
Accounts payable
    1,825,009       1,538,797  
Accrued expenses and other liabilities
    2,256,561       1,997,312  
                 
Total current liabilities
    5,993,211       7,434,916  
                 
Capital lease obligations, net of current portion
    2,768,261       3,344,820  
                 
Total liabilities
    8,761,472       10,779,736  
                 
Shareholders' equity
               
Preferred stock, $0.001 par value, non-voting 10,000,000
               
shares authorized, no shares issued and outstanding
    -       -  
Common stock, $0.04 par value, 100,000,000 shares authorized
         
6,746,296 and 6,631,576 shares issued and outstanding
    269,849       265,260  
Additional paid-in capital
    16,403,768       16,235,368  
Accumulated deficit
    (6,237,655 )     (8,636,575 )
                 
Total Emergent Group equity
    10,435,962       7,864,053  
Minority Interest
    723,053       696,430  
Total shareholders' equity
    11,159,015       8,560,483  
                 
 Total liabilities and shareholders' equity
  $ 19,920,487     $ 19,340,219  

 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
3


Emergent Group Inc. and Subsidiaries
 
Condensed Consolidated Statements of Income
 
(Unaudited)
 
                         
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2009
   
2008
   
2009
   
2008
 
                         
Revenue
  $ 7,981,464     $ 6,394,974     $ 23,105,272     $ 15,800,812  
Cost of goods sold
    4,802,495       3,751,747       13,839,056       9,067,764  
Gross profit
    3,178,969       2,643,227       9,266,216       6,733,048  
Selling, general, and administrative expenses     1,490,174       1,498,459       4,442,338       3,753,553  
Income from operations
    1,688,795       1,144,768       4,823,878       2,979,495  
                                 
Other income (expense)
                               
Interest expense, net
    (85,692 )     (79,800 )     (261,681 )     (205,936 )
Gain on disposal of property and equipment     5,500       -       8,050       28,937  
Other income, net
    76       9,298       30,336       33,422  
Total other income (expense)
    (80,116 )     (70,502 )     (223,295 )     (143,577 )
                                 
Income before provision for income taxes
                 
and minority interest
    1,608,679       1,074,266       4,600,583       2,835,918  
Provision for income taxes
    (553,000 )     (77,972 )     (1,604,634 )     (213,472 )
Income before minority interest
    1,055,679       996,294       2,995,949       2,622,446  
Minority interest in income of consolidated
               
limited liability companies
    (225,023 )     (254,484 )     (597,030 )     (737,368 )
                                 
Net income
  $ 830,656     $ 741,810     $ 2,398,919     $ 1,885,078  
Basic earnings per share
  $ 0.12     $ 0.12     $ 0.36     $ 0.32  
Diluted earnings per share
  $ 0.12     $ 0.11     $ 0.34     $ 0.30  
Basic weighted-average shares outstanding
    6,745,663       6,183,074       6,710,175       5,856,867  
Diluted weighted-average shares outstanding
    7,089,598       6,606,416       7,059,774       6,284,005  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
4

 
Emergent Group Inc. and Subsidiaries
 
Condensed Consolidated Statements of Cash Flows
 
(Unaudited)
 
   
Nine Months Ended
 
   
September 30,
 
   
2009
   
2008
 
             
Cash flows from operating activities
           
Net income
  $ 2,398,919     $ 1,885,078  
Adjustments to reconcile net income to net cash
               
provided by operating activities:
               
Depreciation and amortization
    1,620,057       1,169,883  
Amortization of finance fees
    -       4,167  
Gain on disposal of property and equipment
    (8,050 )     (28,937 )
Provision for doubtful accounts
    21,415       32,524  
Minority interest in income
    597,030       737,368  
Stock-based compensation expense
    170,494       203,702  
Deferred income taxes
    1,217,122       -  
Other expense - noncash
    5,497       -  
(Increase) decrease in assets and liabilities, net of assets acquired
               
 Accounts receivable
    (547,292 )     (1,102,861 )
 Inventory
    2,315       69,457  
 Prepaid expenses
    (89,329 )     (81,478 )
 Deposits and other assets
    (125,377 )     (8,152 )
Increase (decrease) in
               
Accounts payable
    396,288       364,281  
Accrued expenses and other liabilities
    262,699       102,019  
                 
Net cash provided by operating activities
    5,921,788       3,347,051  
                 
Cash flows from investing activities
               
Purchase of property and equipment
    (517,582 )     (331,554 )
Purchase of assets from PhotoMedex
    -       (1,399,735 )
Cash paid to members of limited liability companies
    (703,404 )     (697,621 )
Contributions from new members to limited liability companies
    112,500       84,375  
Proceeds from the sale of property and equipment
    4,050       29,978  
                 
Net cash used in investing activities
    (1,104,436 )     (2,314,557 )
                 
Cash flows from financing activities
               
Payments on capital lease obligations
    (1,492,241 )     (942,485 )
Payments on dividends declared
    (1,989,750 )     (1,686,095 )
Borrowings under line of credit
    -       8,172,638  
Repayments on line of credit
    -       (8,172,638 )
Payments on notes payable
    -       (75,667 )
Proceeds from private placement of common stock
    -       1,130,890  
Proceeds from equipment refinancing
    34,740       75,000  
Proceeds from exercise of common stock options
    1,600       -  
                 
Net cash used in financing activities
    (3,445,651 )     (1,498,357 )
                 
Net increase (decrease) in cash
    1,371,701       (465,863 )
                 
Cash, beginning of period
    4,586,107       3,043,654  
                 
Cash, end of period
  $ 5,957,808     $ 2,577,791  
                 
Supplemental disclosures of cash flow information:
               
Interest paid
  $ 273,343     $ 225,395  
Income taxes paid
  $ 502,147     $ 292,497  
                 
 
Supplemental schedule of noncash investing and financing activities:
 
During the nine months ended September 30, 2009 and 2008, the Company incurred capital lease obligations
 
of $918,266 and $2,913,444, respectively, for medical equipment. The lease obligation of $2,913,444 incurred
 
during the nine months ended September 30, 2008 includes $1,750,000 of equipment financing incurred in
 
connection with the acquisition of the assets of the Services Division from PhotoMedex, Inc., as further
 
discussed herein. In addition, equipment purchases of $271,750 are included in accounts payable in the
 
accompanying balance sheet as of September 30, 2009 for which the Company is arranging lease financing.

The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
5

 
EMERGENT GROUP INC and SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Three and Nine Months Ended September 30, 2009 and 2008

1.  
BUSINESS

Emergent Group Inc. (“Emergent”) is the parent company of PRI Medical Technologies, Inc. (“PRI Medical”), its wholly owned subsidiary. Emergent and PRI Medical are referred to collectively hereinafter as the “Company.” PRI Medical provides mobile laser/surgical services, along with technical support, on a per procedure basis to hospitals, out-patient surgery centers, and physicians' offices.

As further discussed herein, on August 8, 2008 the Company acquired the assets of the Surgical Services Division (the “Services Division”) of PhotoMedex, Inc. The operating results for the three and nine months ended September 30, 2009 include the results of operations for the Services Division. In addition, unaudited pro forma information is presented in Note 7 below for the same periods in 2008 assuming that the acquisition of assets had occurred on the dates stated therein.

In May 2009, the Company purchased certain medical equipment from a limited liability company for approximately $111,000. The purchase price was satisfied through the use of lease financing.

2.  
BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Emergent have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary for a fair presentation of the results for the periods presented.

The results of operations presented for the three and nine months ended September 30, 2009 and 2008 are not necessarily indicative of the results to be expected for any other interim period or any future fiscal year.
 
Principles of Consolidation
The consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. Also, in accordance with the guidance issued by the Financial Accounting Standards Board (“FASB”), the Company has accounted for its minority equity investments in certain limited liability companies under the full consolidation method. All significant intercompany transactions and balances have been eliminated through consolidation.

Use of Estimates
The preparation of the condensed consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of income and expenses during the reporting period. Actual results could differ significantly from those estimates.

Accounts Receivable and Concentration of Business and Credit Risks
We market our services primarily to hospitals, out-patient centers and physicians throughout 16 states located in the Western and Eastern United States. Our equipment rental and technician services are subject to competition from other similar businesses. Our accounts receivable represent financial instruments with potential credit risk. We offer credit terms and credit limits to most of our customers based on the creditworthiness of such customers. However, we retain the right to place such customers on credit hold should their account become delinquent. We maintain an allowance for doubtful accounts for estimated losses should customers fail to make required payments. In addition, we monitor the age of customer account balances, historical bad debt experience, customer creditworthiness, customer specific information, and changes in payment patterns when making estimates of the collectibility of trade receivables. Accounts receivable are written off when all collection attempts have failed. Our allowance for doubtful accounts will be increased if circumstances warrant. Based on the information available, management believes that our net accounts receivable are collectible.
 
 
6


Inventory
Inventory consists of finished goods primarily used in connection with the delivery of our mobile surgical equipment rental and services business. Inventory is stated at the lower of cost or market, on a first-in, first-out basis.

Stock-Based Compensation
 
Compensation costs related to stock options are determined in accordance with guidance issued by the FASB, using the modified prospective method. Under this method, compensation cost recognized during the three and nine months ended September 30, 2009 and 2008 includes compensation cost for all share-based payments granted prior to but not yet vested as of January 1, 2006, and all grants subsequent to that date, based on the grant date fair value, which is amortized over the remaining vesting period for such options. During March and April 2009 we issued 15,500 and 14,500 stock options to various employees, respectively. Such options generally vest in equal installments over five years and unvested options are subject to forfeiture should the respective employee leave the company. Compensation costs related to total stock options outstanding for the three months ended September 30, 2009 and 2008 were $3,858 and $3,178, respectively, and $11,420 and $9,107 for the nine months ended September 30, 2009 and 2008, respectively.
 
The 2002 Employee Benefit and Consulting Services Compensation Plan (the “2002 Plan”) was adopted in 2002 for the purpose of providing incentives to key employees, officers, directors, and consultants of the Company who provide significant services to the Company. As of September 30, 2009, there are 650,000 common shares authorized for grant under the 2002 Plan. Options will not be granted for a term of more than ten years from the date of grant. Generally, options will vest evenly over a period of five years, and the 2002 Plan expires in March 2012. Incentive stock options granted under the 2002 Plan are non-statutory stock options. As of September 30, 2009, the number of shares reserved for future awards was 96,827, which is net of the 53,500 restricted award shares granted in April 2009 under the 2002 Plan, as discussed below.
 
On June 29, 2009 our shareholder’s approved the 2009 Employee Benefit and Consulting Services Compensation Plan (the “2009 Plan”). The 2009 Plan was adopted for the purpose of providing incentives to key employees, officers, directors, and consultants of the Company who provide significant services to the Company. The Company may issue up to 300,000 incentive and non-statutory stock options and common stock awards under this plan. Options and awards granted to employees will vest over five years and are subject to forfeiture if the employee terminates prior to vesting. The 2009 Plan will terminate and no awards may be granted after June 28, 2019. As of September 30, 2009 there have been no options or awards granted under the 2009 Plan.
 
A summary of the Company's outstanding stock options and activity is as follows:
 
   
Number of Shares
   
Weighted Average Exercise Price
 
             
Outstanding at January 1, 2009
    336,639     $ 1.59  
Options Granted
    30,000     $ 5.68  
Options Canceled
    (5,532 )   $ 5.54  
Options Exercised
    (40,460 )   $ 0.47  
Outstanding at September 30, 2009
    320,647     $ 2.05  
Exercisable at September 30, 2009
    257,620     $ 1.66  
 
 
7

 
The weighted-average remaining contractual life of the options outstanding at September 30, 2009 is 4.80 years. The exercise prices for the options outstanding at September 30, 2009 ranged from $0.40 to $51.00, and information relating to these options is as follows:
 
               
Weighted
Weighted
 
Weighted
   
Weighted
 
               
Average
Average
 
Average
   
Average
 
Weighted-
   
Weighted
       
Remaining
Remaining
 
Exercise
   
Exercise
 
Range of
   
Stock
   
Stock
 
Contractual
Contractual
 
Price of
   
Price of
 
Exercise
   
Options
   
Options
 
Life of Options
Life of Options
 
Options
   
Options
 
Prices
   
Oustanding
   
Exercisable
 
Outstanding
Exercisable
 
Outstanding
   
Exercisable
 
                               
$ 0.40       240,575       235,790  
3.66 years
3.63 years
  $ 0.40     $ 0.40  
$ 2.15 - 8.00       73,000       14,758  
8.84 years
8.03 years
  $ 3.91     $ 3.88  
$ 20.00 - 51.00       7,072       7,072  
1.98 years
1.98 years
  $ 38.96     $ 38.96  
$ 0.40 - 51.00       320,647       257,620  
4.80 years
3.84 years
  $ 2.05     $ 1.66  
 
As of September 30, 2009, the total unrecognized compensation cost related to unvested stock options was $39,242, which is to be recognized over a remaining weighted average vesting period of approximately 3.63 years.
 
         
Weighted
             
         
Average
         
Weighted
 
         
Remaining
   
Weighted
   
Average
 
   
Number
   
Vesting Life
   
Average
   
Grant Date
 
   
Outstanding
   
(in years)
   
Exercise Price
   
Fair Value
 
                         
Non Vested, December 31, 2008
    64,411       2.93     $ 1.76     $ 0.34  
Granted
    30,000             $ 5.68     $ 0.66  
Forfeited
    (5,532 )           $ 5.54     $ 0.15  
Vested
    (25,852 )           $ 0.40     $ 0.40  
Non Vested, September 30, 2009
    63,027       3.63     $ 3.64     $ 0.48  

In addition to options granted under the 2002 Plan, as of September 30, 2009, we have 409,409 restricted award shares issued and outstanding of which 355,909 were issued outside of the 2002 Plan and 128,100 are fully vested. We issued 53,500 restricted award shares to executive officers and directors in April 2009 pursuant to our 2002 Plan and restricted shares of 105,000 were issued to executive officers, directors and employees in March 2008. Award shares vest in equal installments over five years from the date of issuance. Such award shares are issued from time to time to executive officers, directors and employees of the Company. Non-vested award shares are subject to forfeiture in the event that the recipient is no longer employed by the Company at the time of vesting, subject to the Board’s right to waive the forfeiture provisions. Compensation expense related to such shares is determined as of the issuance date based on the fair value of the shares issued and is amortized over the related vesting period. Total fair value related to the award shares issued in April 2009 and March 2008 was $363,265 and $320,250, respectively. Compensation costs are amortized over the vesting period of five years. Compensation expense related to outstanding restricted award shares was $59,421 and $40,247 for the three months ended September 30, 2009 and 2008, respectively, and $159,074 and $105,214 for the nine months ended September 30, 2009 and 2008, respectively.

Earnings Per Share
Basic earnings per share are computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding.  Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common share equivalents had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.
 
 
8


   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2009
   
2008
   
2009
   
2008
 
Numerator -
Net income attributable to common
shareholders
  $ 830,656     $ 741,810     $ 2,398,919     $ 1,885,078  
Denominator -
Weighted-average number of common
shares outstanding during the period
    6,745,663       6,183,074       6,710,175       5,856,867  
 Dilutive effect of stock options and warrants
    343,935       423,342       349,599       427,138  
Common stock and common stock
equivalents used for diluted earnings per share
    7,089,598       6,606,416       7,059,774       6,284,005  
 
 
Recent Accounting Pronouncements
During the third quarter ended September 30, 2009, we adopted changes issued by the FASB to the authoritative hierarchy of GAAP. These changes establish the FASB Accounting Standards CodificationTM (Codification) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. Rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts; instead the FASB will issue Accounting Standards Updates (ASU). ASU’s will not be authoritative in their own right as they will only serve to update the Codification. These changes and the Codification itself do not change GAAP. Other than the manner in which new accounting guidance is referenced, the adoption of these changes had no impact on our consolidated financial statements.

We recently adopted changes issued by the FASB to accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued, otherwise known as “subsequent events.” Specifically, these changes set forth the period after the balance sheet date during which management of a reporting entity should evaluate events or transactions that may occur for potential recognition or disclosure in the financial statements, the circumstances under which an entity should recognize events or transactions occurring after the balance sheet date in its financial statements, and the disclosures that an entity should make about events or transactions that occurred after the balance sheet date. The adoption of these changes had no impact on our consolidated financial statements as management already followed a similar approach prior to the adoption of this new guidance. We have evaluated subsequent events through November 9, 2009, the filing date of this quarterly report, and there is no material impact on to our consolidated financial statements.

In August 2009, the FASB issued ASU 2009-15, which changes the fair value accounting for liabilities. These changes clarify existing guidance that in circumstances in which a quoted price in an active market for the identical liability is not available, an entity is required to measure fair value using either a valuation technique that uses a quoted price of either a similar liability or a quoted price of an identical or similar liability when traded as an asset, or another valuation technique that is consistent with the principles of fair value measurements, such as an income approach (e.g., present value technique). This guidance also states that both a quoted price in an active market for the identical liability and a quoted price for the identical liability when traded as an asset in an active market when no adjustments to the quoted price of the asset are required are Level 1 fair value measurements. This ASU is effective on January 1, 2010. Adoption of this ASU is will not have an impact on our consolidated financial statements.

In June 2009, the FASB issued changes to the accounting for variable interest entities. These changes require an enterprise to perform an analysis to determine whether the enterprise’s variable interest or interests give it a controlling financial interest in a variable interest entity; to require ongoing reassessments of whether an enterprise is the primary beneficiary of a variable interest entity; to eliminate the quantitative approach previously required for determining the primary beneficiary of a variable interest entity; to add an additional reconsideration event for determining whether an entity is a variable interest entity when any changes in facts and circumstances occur such that holders of the equity investment at risk, as a group, lose the power from voting rights or similar rights of those investments to direct the activities of the entity that most significantly impact the entity’s economic performance; and to require enhanced disclosures that will provide users of financial statements with more transparent information about an enterprise’s involvement in a variable interest entity. These changes become effective for us beginning on January 1, 2010. The adoption of this change is not expected to have a material impact on our consolidated financial statements.
 
In June 2009, the FASB issued changes to the accounting for transfers of financial assets. These changes remove the concept of a qualifying special-purpose entity and remove the exception from the application of variable interest accounting to variable interest entities that are qualifying special-purpose entities; limits the circumstances in which a transferor derecognizes a portion or component of a financial asset; defines a participating interest; requires a transferor to recognize and initially measure at fair value all assets obtained and liabilities incurred as a result of a transfer accounted for as a sale; and requires enhanced disclosure; among others. These changes will become effective for us on January 1, 2010.
 
3.     DEBT OBLIGATIONS
 
The Company entered into a new credit agreement (the “Agreement”) with a bank in June 2008, which was amended and renewed in August 2009. The Agreement, as amended, provides for a line of credit of $1.5 million and is collateralized by substantially all unencumbered assets of the Company. Advances under the Agreement bear interest at the prime rate, plus one-half of one percent (3.75% as of September 30, 2009), with interest payable monthly. Subject to the terms of the Agreement, the Company may request and repay advances from time to time through the expiration date. The Agreement includes certain financial covenants that must be met including a covenant that for a period of not less than thirty (30) consecutive days during the loan term, that no loan amount will be outstanding under the Agreement. The Agreement expires on August 3, 2010. As of September 30, 2009 the Company was in compliance with the terms of its revolving credit agreement and no amounts have been drawn under this facility.
 

9

 
In connection with the acquisition of the Services Division, we entered into an equipment lease financing loan with a bank for $1,750,000. The equipment lease is collaterialized by the acquired assets and other assets of the Company and provides for monthly payments of principal and interest of $46,378 commencing on September 1, 2008 over 42 months, with interest at 6.4%. The lease financing agreement also requires Emergent to meet certain financial covenants over the loan term. As of September 30, 2009 the Company was in compliance with terms of this loan agreement.

The Company incurred total net interest expense of $85,692 and $79,800 for the three months ended September 30, 2009 and 2008, respectively and $261,681 and $205,936 for the nine months ended September 30, 2009 and 2008, respectively.
 
4.
COMMITMENTS AND CONTINGENCIES
 
Legal Matters
 
Byong Y. Kwon, Plaintiff against Daniel J. Yun, Emergent Group Inc., Emergent Capital Investment Management, LLC, Metedeconk Holdings, LLC, Voyager Advisors, LLC, Millennium Tradition Limited (f/k/a Millennium Heritage, Limited), Emergent Management Company, LLC, Endurance Advisors, Limited, SK Networks Co., Ltd. (f/k/a SK Global Co., Ltd.), Hye Min Kang, John Does 1-2 and Richard Roes 1-2 (collectively the “Defendants”).

Plaintiff’s complaint against the Defendants named above is a civil lawsuit, which was signed by the clerk on February 2, 2005. This action is brought in the United States District Court, Southern District of New York by Plaintiff against the Company, a former director, Daniel Yun, and other parties to recover money damages for alleged fraud, negligent misrepresentations and aiding and abetting fraud. The Amended Complaint alleges that the factual basis involving the action against the Company involves alleged false representations to Plaintiff to induce him to leave his then employment in 2001 and accept the Company’s and another named Defendant’s alleged offer of employment. Plaintiff seeks compensatory damages and punitive damages each in the amount of not less than $2,100,000 together with interest thereon, reasonable attorneys’ fees and other specific relief against Defendants other than the Company. Management has denied the Plaintiff’s allegations against the Company and intends to vigorously defend this lawsuit. During the quarter ended September 30, 2009 there were no material developments in this matter.
 
5.     RELATED PARTY TRANSACTIONS

Transactions with BJH Management
 
The services of the Company’s Chairman and Chief Executive Officer are contracted through BJH Management for a monthly fee of $15,167. In March 2007, the services agreement with BJH Management was extended to June 30, 2010.

The Company’s Chairman and Chief Executive Officer maintains his primary office in New York. In this regard, the Company reimbursed BJH Management, LLC (“BJH”), a company owned by the Company’s Chairman and Chief Executive Officer, for office rent and other reimbursable expenses totaling $18,073 and $13,064 for the three months ended September 30, 2009 and 2008, respectively, and $52,173 and $33,551 for the nine months ended September 30, 2009 and 2008, respectively.

6.     LIMITED LIABILITY COMPANIES

In connection with expanding its business, PRI Medical participates with others in the formation of Limited Liability Companies (“LLCs”) in which it will acquire either a minority or majority interest and the remaining interests are held by other investors. These LLCs acquire certain medical equipment for use in their respective business activities which generally focus on surgical procedures. As of September 30, 2009, PRI Medical holds interests in ten LLCs located in California, Colorado and New York. We previously held interests in thirteen LLCs; however, during third quarter of 2009 three LLCs ceased operations and we began the wind-down and dissolution process. We purchased the assets, primarily representing a customer list, from one such LLC for $95,000, less any wind-down and dissolution expenses. The purchase price is due in two equal installments with payments due in November 2009 and January 2010. Our LLCs acquire medical equipment for rental purposes under equipment financing leases. The third party investors in each respective LLC generally provide the lease financing company with individual proportionate lease guarantees based on their respective ownership percentages in the LLCs. In addition, PRI Medical will provide such financing companies with its corporate guarantee based on its respective ownership interest in each LLC. In certain instances, PRI Medical has provided such financing companies with an overall corporate guarantee in connection with equipment financing transactions. In such instances, the individual investors in each respective LLC will generally indemnify PRI Medical against losses, if any, incurred in connection with its corporate guarantee.

7.     ACQUISITION OF THE ASSETS OF THE SERVICES DIVISION OF PHOTOMEDEX, INC.

On August 2, 2008, the Company entered into an agreement to acquire the assets of the Surgical Services Division (the “Services Division”) of PhotoMedex, Inc. The Services Division provides mobile laser services in 11 Northeast, Middle Atlantic and Southeast states, serving 18 individual local markets, expanding PRI’s geographic coverage to a total of 16 states. Revenues of the Services Division were $7,667,000 for the year ended December 31, 2007. The purchase price for the Services Division was approximately $3,149,735, subject to certain post closing adjustments, plus closing costs. The acquisition was closed on August 8, 2008, at which time the purchase price was paid by the Company through borrowings from a bank of $1,750,000 under a fully amortizing capital equipment lease arrangement, which is collateralized by the acquired assets and other assets of the Company, the proceeds from the private sale of our restricted Common Stock as discussed below, with the balance paid from existing cash.

 
10

 
The purchase price for the acquired assets of $3,149,735, plus certain acquisition costs, was allocated to accounts receivable of $761,959, inventory of $467,720, equipment and vehicles of $1,594,670 and to customer list for $358,864. Equipment and vehicles are being depreciated over three to five years while the customer list is being amortized over ten years.
 
In connection with the acquisition of the assets of the Services Division, on July 31, 2008, the Company received investment commitments totaling $1,130,890 from 15 investors to purchase the Company’s Common Stock. The commitments consisted of 665,229 Units at an offering price of $1.70 per Unit. Each Unit consisted of one share of Common Stock and a Warrant to purchase 0.6 shares of Common Stock at an exercise price of $1.75 per whole share. The Warrants expire at the close of business on July 31, 2013. Of the 665,229 Units, 533,825 Units (equivalent to $907,503) were purchased by officers and directors of the Company.
 
Our acquisition of the Services Division in August 2008 has impacted our operating results for the nine months ended September 30, 2009 compared to the same period last year as discussed below.
 
Unaudited Pro Forma Results of Operations for the Three and Nine Months Ended September 30, 2008

The historical operating results for the Company include the operating results for the Services Division from January 1, 2009 to September 30, 2009. Presented below are the summarized pro forma operating results and earnings per share for the Company assuming that the acquisition of assets of the Services Division had been completed on January 1, 2008, with pro forma results presented from January 1, 2008 through August 8, 2008, after which our historical results are included in such pro forma results of operations.

   
Pro Forma Results of Operations
 
   
Three Months
   
Nine Months
 
   
Ended
   
Ended
 
   
September 30,
   
September 30,
 
   
2008
   
2008
 
             
Pro forma revenue
  $ 7,131,272     $ 20,198,859  
                 
Pro forma income from operations
  $ 1,207,800     $ 3,315,288  
                 
Pro forma provision for income taxes
  $ (81,885 )   $ (234,043 )
                 
Pro forma net income
  $ 790,074     $ 2,138,789  
                 
Pro forma basic earnings per share
  $ 0.12     $ 0.34  
                 
Pro forma diluted earnings per share
  $ 0.12     $ 0.31  

The unaudited pro forma condensed results of operations for 2008 include pro forma adjustments for the period from January 1, 2008 to August 8, 2008 to adjust depreciation and amortization expense based on asset values and related depreciation and amortization periods ascribed by the Company, interest expense incurred in connection with acquisition financing, certain acquisition related costs, and the estimated impact on state taxes related to the income of the Services Division. In connection with the acquisition transaction, Emergent raised additional capital through the private placement of its Common Stock and the issuance of Warrants to purchase Common Stock in July 2008. The pro forma common and fully diluted shares outstanding assume completion of this transaction on January 1, 2008 and include the effects of this transaction in its basic and fully diluted shares outstanding. The issuance of the Warrants resulted in compensation expense of $93,937, which is also included in the pro forma adjustments for the nine months ended September 30, 2008.

The unaudited pro forma results for the periods presented above are not necessarily indicative of what actual results would have resulted had the acquisition transaction described herein occurred at the dates stated above nor do they purport to indicate the results of future operations of Emergent and the Services Division acquired from PhotoMedex, Inc. Furthermore, no effect has been given in the unaudited pro forma condensed statements of income for synergistic benefits that may be realized from the acquisition of the Services Division or costs that may have been incurred in integrating operations. The unaudited condensed pro forma combined statements of income as presented herein should be read in conjunction with the accompanying notes, the historical financial statements and notes to the financial statements of Emergent set forth in Emergent’s periodic and current reports filed with the Securities and Exchange Commission and the carve-out audited and unaudited financial statements and notes of the Services Division as previously filed in Form 8-K.
 
 
11


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

The information contained in this Form 10-Q and documents incorporated herein by reference are intended to update the information contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 and such information presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors” and other information contained in such Form 10-K and other Company filings with the Securities and Exchange Commission (“SEC”).

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties, and actual results could be significantly different than those discussed in this Form 10-Q. Certain statements contained in Management's Discussion and Analysis, particularly in "Liquidity and Capital Resources," and elsewhere in this Form 10-Q are forward-looking statements. These statements discuss, among other things, expected growth, future revenues and future performance. Although we believe the expectations expressed in such forward-looking statements are based on reasonable assumptions within the bounds of our knowledge of our business, a number of factors could cause actual results to differ materially from those expressed in any forward-looking statements, whether oral or written, made by us or on our behalf. The forward-looking statements are subject to risks and uncertainties including, without limitation, the following: (a) changes in levels of competition from current competitors and potential new competition, (b) possible loss of significant customer(s), (c) the Company’s ability to effectively integrate into its operations the recently acquired assets and customers of the Surgical Services Division of PhotoMedex, Inc., as discussed elsewhere in this Form 10-Q, and its ability to integrate new and changing medical technologies into to its product and service offerings, (d) the risk of equipment vendors not making their equipment and technologies available to equipment rental and service companies such as ours, (e) the Company’s ability to meet the terms and conditions of its debt and lease obligations, (f) the potential impact of new government rules and regulations could have a material adverse affect on our results of our operations, and (g) changes in availability or terms of working capital financing from vendors and lending institutions. The foregoing should not be construed as an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by us. All forward-looking statements included in this document are made as of the date hereof, based on information available to the Company on the date thereof, and the Company assumes no obligation to update any forward-looking statements.

Overview

Emergent Group Inc. (“Emergent”) is the parent company of PRI Medical Technologies, Inc. (“PRI Medical”), its wholly owned subsidiary. Emergent and PRI Medical are referred to collectively hereinafter as the “Company.” PRI Medical provides mobile laser/surgical services, along with technical support, on a per procedure basis to hospitals, out-patient surgery centers, and physicians' offices.

Acquisition of the Assets of the Services Division of PhotoMedex, Inc.

On August 2, 2008, the Company entered into an agreement to acquire the assets of the Surgical Services Division (the “Services Division”) of PhotoMedex, Inc. The Services Division provides mobile laser services in 11 Northeast, Middle Atlantic and Southeast states, serving 18 individual local markets expanding PRI’s geographic coverage to a total of 16 states. Revenues of the Services Division were $7,667,000 for the year ended December 31, 2007. The purchase price for the Services Division was approximately $3,149,735, subject to certain post closing adjustments, plus closing costs. The acquisition was closed on August 8, 2008, at which time the purchase price was paid by the Company through borrowings from a bank of $1,750,000, under a fully amortizing capital equipment lease arrangement, which is collateralized by the acquired assets and other assets of the Company, the proceeds from the private sale of our restricted Common Stock as discussed elsewhere in this Form 10-Q, with the balance paid from existing cash.

Our acquisition of the Services Division in August 2008 has impacted our operating results for the nine months ended September 30, 2009 compared to the same period last year as discussed below.
 
12

 
Unaudited Pro Forma Results for the Three and Nine Months Ended September 30, 2008

The historical operating results for the Company include the operating results for the Services Division from January 1, 2009 to September 30, 2009. Presented below are the summarized pro forma operating results and earnings per share for the Company assuming that the acquisition of assets of the Services Division had been completed on January 1, 2008, with pro forma results presented from January 1, 2008 through August 8, 2008, after which our historical results are included in such pro forma results of operations.
 
   
Pro Forma Results of Operations
 
   
Three Months
   
Nine Months
 
   
Ended
   
Ended
 
   
September 30,
   
September 30,
 
   
2008
   
2008
 
             
Pro forma revenue
  $ 7,131,272     $ 20,198,859  
                 
Pro forma income from operations
  $ 1,207,800     $ 3,315,288  
                 
Pro forma provision for income taxes
  $ (81,885 )   $ (234,043 )
                 
Pro forma net income
  $ 790,074     $ 2,138,789  
                 
Pro forma basic earnings per share
  $ 0.12     $ 0.34  
                 
Pro forma diluted earnings per share
  $ 0.12     $ 0.31  

The unaudited pro forma condensed results of operations for 2008 include pro forma adjustments for the period from January 1, 2008 to August 8, 2008 to adjust depreciation and amortization expense based on asset values and related depreciation and amortization periods ascribed by the Company, interest expense incurred in connection with acquisition financing, certain acquisition related costs, and the estimated impact on state taxes related to the income of the Services Division. In connection with the acquisition transaction Emergent raised additional capital through the private placement of its Common Stock and the issuance of Warrants to purchase Common Stock in July 2008. The pro forma common and fully diluted shares outstanding assume completion of this transaction on January 1, 2008 and include the effects of this transaction in its basic and fully diluted shares outstanding. The issuance of the Warrants resulted in compensation expense of $93,937, which is also included in the pro forma adjustments for the nine months ended September 30, 2008.

The unaudited pro forma results for 2008 are not necessarily indicative of what actual results would have resulted had the acquisition transaction described herein occurred on the dates stated above nor do they purport to indicate the results of future operations of Emergent and the Services Division acquired from PhotoMedex, Inc. Furthermore, no effect has been given in the unaudited pro forma condensed statements of income for synergistic benefits that may be realized from the acquisition of the Services Division or costs that may be incurred in integrating operations. The unaudited condensed pro forma combined statements of income as presented herein should be read in conjunction with the accompanying notes, the historical financial statements and notes to the financial statements of Emergent set forth in Emergent’s periodic and current reports filed with the Securities and Exchange Commission and the carve-out audited and unaudited financial statements and notes of the Services Division as previously filed in Form 8-K.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of financial statements requires managers to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates including, but not limited to, those related to revenue recognition, inventory valuation and property and equipment. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our financial statements.

Revenue Recognition. Revenue is recognized once our mobile rental and technicians services are performed and billable. We are required to make judgments based on historical experience and future expectations, as to the realizability of goods and services billed to our customers. These judgments are required to assess the propriety of the recognition of revenue based on Staff Accounting Bulletin (“SAB”) No. 104, “Revenue Recognition,” and related guidance. We make such assessments based on the following factors: (a) customer-specific information, and (b) historical experience for issues not yet identified.
Inventory Valuation. We are required to make judgments based on historical experience and future expectations as to the realizability of our inventory. We make these assessments based on the following factors: (a) existing orders and usage, (b) age of the inventory, and (c) historical experience.
 
13


Property and Equipment. We are required to make judgments based on historical experience and future expectations as to the realizability of our property and equipment. We made these assessments based on the following factors: (a) the estimated useful lives of such assets, (b) technological changes in our industry, and (c) the changing needs of our customers.

Results of Operations

The following table sets forth certain selected unaudited condensed consolidated statements of income data for the periods indicated in dollars and as a percentage of total revenues. The following discussions relate to our results of operations for the periods noted which include the results of operations for the Services Division acquired on August 8, 2008, as discussed herein, for the periods from January 1, 2009 to September 30, 2009 and from August 9, 2008 to September 30, 2008. The results of operations for the periods noted are not necessarily indicative of the results expected for any other interim period or any future fiscal year. In addition, we note that the period-to-period comparison may not be indicative of future performance.

   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2009
   
%
   
2008
   
%
   
2009
   
%
   
2008
   
%
 
                                                 
Revenue
  $ 7,981,464       100 %   $ 6,394,974       100 %   $ 23,105,272       100 %   $ 15,800,812       100 %
Cost of goods sold
    4,802,495       60 %     3,751,747       59 %     13,839,056       60 %     9,067,764       57 %
Gross profit
    3,178,969       40 %     2,643,227       41 %     9,266,216       40 %     6,733,048       43 %
Selling, general, and administrative expenses
    1,490,174       19 %     1,498,459       23 %     4,442,338       19 %     3,753,553       24 %
Income from operations
    1,688,795       21 %     1,144,768       18 %     4,823,878       21 %     2,979,495       19 %
Other income (expense)
    (80,116 )     -1 %     (70,502 )     -1 %     (223,295 )     -1 %     (143,577 )     -1 %
Income before provision for income
taxes and minority interest
    1,608,679       20 %     1,074,266       17 %     4,600,583       20 %     2,835,918       18 %
Provision for income taxes
    (553,000 )     -7 %     (77,972 )     -1 %     (1,604,634 )     -7 %     (213,472 )     -1 %
Net income before minority interest
    1,055,679       13 %     996,294       16 %     2,995,949       13 %     2,622,446       17 %
Minority interest in income of consolidated
limited liability companies
    (225,023 )     -3 %     (254,484 )     -4 %     (597,030 )     -3 %     (737,368 )     -5 %
Net income
  $ 830,656       10 %   $ 741,810       12 %   $ 2,398,919       10 %   $ 1,885,078       12 %
 
Comparison of the Three Months Ended September 30, 2009 to September 30, 2008

The Company generated revenues of $7,981,464 in 2009 compared to $6,394,974 in 2008. The increase in revenues in 2009 of $1,586,490, or 25% is primarily related to the inclusion of revenues from the Services Division, which we acquired in August 2008 and from an increase in revenues from our other surgical procedures.

Cost of goods sold was $4,802,495 in 2009 or 60% of revenues, compared to $3,751,747 or 59% of revenues for 2008. Costs of goods sold primarily consist of payroll costs and related expenses for technicians, cost of disposables consumed, depreciation and amortization related to equipment, insurance costs and other operating costs incurred in rendering mobile medical equipment and technician services. The overall increase in cost of goods sold of $1,050,748 or 28% for 2009 is due to the inclusion of costs for the Services Division, which we acquired in August 2008 as well as increases in disposable costs, payroll and related costs, depreciation and amortization expenses and to increases in equipment maintenance costs. Disposable costs increased due to increased sales volume, payroll and payroll related costs increased due to an increase in the number of employees, depreciation and amortization expense increased due to equipment purchases in 2009 and 2008. The net change in other cost categories included in cost of goods sold remained relatively consistent in 2009 compared to 2008.

Gross profit from operations was $3,178,969 in 2009, compared to $2,643,227 in 2008. Gross profit as a percentage of revenues was 40% for 2009 compared to 41% for 2008. Gross margins after disposable costs will vary depending on the type of surgical procedure performed due to the fact that certain procedures require more expensive disposable items. In addition, gross margin rates will vary from period to period depending upon other factors including pricing considerations, and equipment and technician utilization rates. The gross margin for 2009 is not necessarily indicative of the margins that may be realized in future periods.
 
 
14


Selling, general, and administrative expenses were $1,490,174 or 19% of revenues for 2009 and $1,498,459 or 23% of revenues for 2008. Such costs include, among others, payroll and related expenses, insurance costs and occupancy costs. The decrease in selling and general and administrative expenses of $8,285 is related to the fact that we recognized compensation expense of $93,937 in the prior year quarter in connection with our private placement of common stock and certain other acquisition related expenses, while no such expense was recognized in 2009. The decrease in such expenses in 2009 compared to 2008 offset increases in performance-based incentive compensation and to increases in sales management and other payroll related expenses for 2009 compared to 2008

Other income (expense) was $(80,116) in 2009 compared to $(70,502) in 2008. Other income (expense) includes interest income and expense, gains and losses on disposal of property and equipment, and other miscellaneous income and expense items. The net increase in other expense of $9,614 is primarily related to an increase in net interest expense of $5,892; offset by a net decease in gain on the disposal of property and equipment and other income of $3,722. The net increase in interest expense relates to new equipment leases entered into during 2009 and 2008, including the equipment financing lease incurred in connection with the acquisition of the Services Division in August 2008. The net decrease in gain on disposal of property and equipment and other income is related to a decrease in such miscellaneous income items in 2009 compared to 2008.

The minority interest (ownership interests held by third-parties) in net income of limited liability companies was $225,023 in 2009 compared to $254,484 in 2008. In 2009 and 2008, we held ownership interests in thirteen and eleven entities, respectively. During the quarter ended September 30, 2009 three LLCs ceased operations and we began the wind-down and dissolution process. The decrease in minority interest in earnings is related to the winding-down of operations for such LLCs. As of September 30, 2009 and 2008, in accordance with guidance issued by the FASB, the Company accounted for its equity investments in entities in which it holds a minority interest under the full consolidation method.

Net income was $830,656 in 2009 compared to $741,810 in 2008. Provision for income taxes was $553,000 in 2009 as compared to $77,972 in 2008. During the fourth quarter of 2008 we recognized deferred tax benefits of $1,331,512 related to operating losses from prior years. We did not reverse the valuation allowance until it was “more likely than not” that the tax asset would be realized. The provision for income taxes of $553,000 as of September 30, 2009 is comprised of state taxes, federal Alternative Minimum Taxes (AMT), and the utilization of deferred income tax assets. At December 31, 2008, the Company had net operating loss carryforwards of approximately $7.6 million for federal tax purposes. Basic net income per share for 2009 and 2008 was $0.12 and $0.12, respectively, while fully diluted net income per share for 2009 and 2008 was $0.12 and $0.11, respectively. Basic and fully diluted weighted average shares outstanding for 2009 were 6,745,663 and 7,089,598, respectively, and 6,183,074 and 6,606,416 for 2008, respectively.
 
Comparison of the Nine Months Ended September 30, 2009 to September 30, 2008

The Company generated revenues of $23,105,272 in 2009 compared to $15,800,812 in 2008. The increase in revenues in 2009 of $7,304,460, or 46% is primarily related to the inclusion of revenues from the Services Division, which we acquired in August 2008 and from an increase in revenues from our other surgical procedures.

Cost of goods sold was $13,839,056 in 2009 or 60% of revenues, compared to $9,067,764 or 57% of revenues for 2008. Costs of goods sold primarily consist of payroll costs and related expenses for technicians, cost of disposables consumed, depreciation and amortization related to equipment, insurance costs and other operating costs incurred in rendering mobile medical equipment and technician services. The overall increase in cost of goods sold of $4,771,292 or 53% for 2009 is due to the inclusion of costs for the Services Division, which we acquired in August 2008, as well as increases in disposable costs, payroll and related costs, depreciation and amortization expenses and to increases in equipment maintenance costs. Disposable costs increased due to increased sales volume, payroll and payroll related costs increased due to an increase in the number of employees, depreciation and amortization expense increased due to equipment purchases in 2009 and 2008. The net change in other cost categories included in cost of goods sold remained relatively consistent in 2009 compared to 2008.
 
Gross profit from operations was $9,266,216 in 2009 compared to $6,733,048 in 2008. Gross profit as a percentage of revenues was 40% in 2009 compared to 43% in 2008. Gross margins after disposable costs will vary depending on the type of surgical procedure performed due to the fact that certain procedures require more expensive disposable items. In addition, gross margin rates will vary from period to period depending upon other factors including pricing considerations, and equipment and technician utilization rates. The gross margin for 2009 is not necessarily indicative of the margins that may be realized in future periods.
 
15


Selling, general, and administrative expenses were $4,442,338 or 19% of revenues for 2009 and $3,753,553 or 24% of revenues for 2008. Such costs include, among others, payroll and related expenses, insurance costs and occupancy costs. The increase in selling, general and administrative expenses of $688,785 in 2009 is primarily related to increases in performance-based incentive compensation and to increases in sales management and other payroll related expenses.

Other income (expense) was $(223,295) in 2009 compared to $(143,577) in 2008. Other income (expense) includes interest income and expense, gains and losses on disposal of property and equipment, and other miscellaneous income and expense items. The net increase in other expense of $79,718 is primarily related to an increase in net interest expense of $55,745; offset by a net decrease in gain on disposal of property and equipment and other income of $23,973. The net increase in interest expense relates to new equipment leases entered into during 2009 and 2008, including the equipment financing lease incurred in connection with the acquisition of the Services Division in August 2008. The net decrease in gain on disposal of property and equipment and other income is related to a decrease in such miscellaneous income items in 2009 compared to 2008.

The minority interest (ownership interests held by third-parties) in net income of limited liability companies was $597,030 in 2009 compared to $737,368 in 2008. In 2009 and 2008, we held ownership interests in thirteen and eleven entities, respectively. The decrease in the minority interest in income for 2009 is related to the fact that three LLCs ceased operations during the third quarter of 2009 and began the wind-down and dissolution process.  In addition, the LLCs generated lower earnings during the nine months ended September 30, 2009 compared to 2008. As of September 30, 2009 and 2008, in accordance with guidance issued by the FASB, the Company accounted for its equity investments in entities in which it holds a minority interest under the full consolidation method.

Net income was $2,398,919 in 2009 compared to $1,885,078 in 2008. Provision for income taxes was $1,604,634 in 2009 as compared to $213,472 in 2008. During the fourth quarter of 2008 we recognized deferred tax benefits of $1,331,512 related to operating losses from prior years. We did not reverse the valuation allowance until it was “more likely than not” that the tax asset would be realized. The provision for income taxes of $1,604,634 as of September 30, 2009 is comprised of state taxes, federal Alternative Minimum Taxes (AMT), and the utilization of deferred income tax assets. At December 31, 2008 the Company had net operating loss carryforwards of approximately $7.6 million for federal tax purposes. Basic net income per share for 2009 and 2008 was $0.36 and $0.32, respectively, while fully diluted net income per share for 2009 and 2008 was $0.34 and $0.30, respectively. Basic and fully diluted weighted average shares outstanding for 2009 were 6,710,175 and 7,059,774, respectively, and 5,856,867 and 6,284,005 for 2008, respectively.

Liquidity and Capital Resources

The Company entered into a new credit agreement (the “Agreement”) with a bank in June 2008, which was amended and renewed in August 2009. The Agreement, as amended, provides for a line of credit of $1.5 million and is collateralized by substantially all unencumbered assets of the Company. Advances under the Agreement bear interest at the prime rate, plus one-half of one percent (3.75% as of September 30, 2009), with interest payable monthly. Subject to the terms of the Agreement, the Company may request and repay advances from time to time through the expiration date. The Agreement includes certain financial covenants that must be met including a covenant that for a period of not less than thirty (30) consecutive days during the loan term, that no loan amount will be outstanding under the Agreement. The Agreement expires on August 3, 2010. As of September 30, 2009 the Company was in compliance with the terms of its revolving credit agreement and no amounts have been drawn under this facility.

In connection with the acquisition of the Services Division, we entered into an equipment lease financing loan with a bank for $1,750,000. The equipment lease is collaterialized by the acquired assets and other assets of the Company and provides for monthly payments of principal and interest of $46,378 commencing on September 1, 2008 over 42 months, with interest at 6.4%. The lease financing agreement also requires Emergent to meet certain financial covenants over the loan term. As of the filing date of this Form 10-Q, the Company was in compliance with such financial covenants.

In May 2009, the Company purchased certain medical equipment from a limited liability company for approximately $111,000. The purchase price was satisfied through the use of lease financing.
 
16

 
The Company had cash and cash equivalents of $5,957,808 at September 30, 2009. Cash provided by operating activities for the nine months ended September 30, 2009 was $5,921,788. Cash generated from operations includes net income of $2,398,919, depreciation and amortization of $1,620,057, deferred income taxes of $1,217,122, minority interest in net income of $597,030, stock-based compensation of $170,494, an increase in provision for doubtful accounts of $21,415, and increases in accounts payable and accrued expenses of $396,288 and $262,699, respectively; and inventory and other expense-noncash of $7,812; offset by increases in accounts receivable, prepaid expenses, deposits and other assets, and gain on disposal of property and equipment of $547,292; $89,329; $125,377, and $8,050, respectively. Cash used in investing activities was $1,104,436 and consisted of the purchase of property and equipment of $517,582, cash distributions of $703,404 to members of limited liability companies, offset by contributions from new members to limited liability companies of $112,500 and proceeds from the sale of equipment of $4,050. Cash used for financing activities was $3,445,651 and consisted of payment of dividends on common stock of $1,989,750, and payments of $1,492,241 on lease obligations; offset by proceeds of $34,740 and $1,600 from equipment refinancing and the exercise of common stock options, respectively.

The Company had cash and cash equivalents of $2,577,791 at September 30, 2008. Cash provided by operating activities for the nine months ended September 30, 2008 was $3,347,051. Cash generated from operations includes net income of $1,885,078, depreciation and amortization of $1,174,050, minority interest in net income of $737,368, stock-based compensation of $203,702, a decrease in inventory of $69,457, an increase in provision for doubtful accounts of $32,524, increases in accounts payable and accrued expenses and other liabilities of $364,281 and $102,019, respectively; offset by increases in accounts receivable of $1,102,861 and prepaid expenses  and deposits and other assets of $81,478 and $8,152, respectively, and gain on disposal of property and equipment of $28,937. Cash used in investing activities was $2,314,557 and consisted of cash paid of $1,399,735 in connection with the acquisition of the assets of the Services Division, purchase of property and equipment of $331,554, cash distributions of $697,621 to members of limited liability companies, offset by contributions from new members to limited liability companies of $84,375 and proceeds from the sale of equipment of $29,978. Cash used for financing activities was $1,498,357 and consisted of payment of dividends on common stock of $1,686,095, and payments on lease and debt obligations of $942,485 and $75,667; offset by net proceeds of $1,130,890 from the private placement of Common Stock and proceeds of $75,000 from equipment refinancing. In addition, during the nine months ended September 30, 2008 we borrowed and repaid $8,172,638 under our previous revolving line of credit agreement.

We anticipate that our future liquidity requirements will arise from the need to finance our accounts receivable and inventories, and from the need to fund our current debt and lease obligations and capital expenditures. The primary sources of funding for such requirements will be cash generated from operations, borrowings under debt facilities and trade payables, and raising additional capital from the sale of equity or other securities. The Company believes that it can generate sufficient cash flow from these sources to fund its on-going operations for at least the next twelve months.

Item 3. Quantitative and Qualitative Disclosures About  Market Risk
 
Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices. Our primary exposure to market risk is interest rate risk associated with our short term money market investments. The Company does not have any financial instruments held for hedging or other speculative purposes and does not invest in derivative financial instruments, interest rate swaps or other investments that alter interest rate exposure.

Item 4. Controls and Procedures
 
We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commissions rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
 
Under the supervision and with the participation of our management, including our CEO and CFO, an evaluation was performed on the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on that evaluation, our management, including our CEO and CFO, concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
 
There were no changes in the Company’s internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.
 
 
17

 
PART II.  OTHER INFORMATION
.
Item 1. 
Legal Proceedings

See Note 4 to Notes to Condensed Consolidated Financial Statements included herein for a description of legal matters.

Item 1A.    
Risk Factors

As a  Smaller Reporting Company as defined Rule 12b-2 of the Exchange Act and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item 1A.

Item 2. 
Changes in Securities

None.

Item 3.  
Defaults Upon Senior Securities

 
None.

Item 4.   
Submissions of Matters to a Vote of Security Holders

In the third quarter ended September 30, 2009 there were no matters submitted to a vote of security holders.

Item 5. 
Other Information

None

Item 6. 
Exhibits

Except for the exhibits listed below, other required exhibits have been previously filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended.

Number   Exhibit Description 
10.1     Second Amendment to Credit Agreement, dated August 18, 2009*
     
11.1   Statement re: computation of earnings per share.  See condensed consolidated statement of operations and notes thereto.
     
31(a)    Rule 13a-14(a) Certification – Chief Executive Officer *
     
31(b)    Rule 13a-14(a) Certification – Chief Financial Officer *
     
32(a)   Section 1350 Certification – Chief Executive Officer *
     
32(b)    Section 1350 Certification – Chief Financial Officer *
     
99.1   Press Release, dated November 4, 2009 Re: Quarterly Results*
     
* Filed herewith.
 
 
18

 
SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
EMERGENT GROUP INC.
 
       
Date: November 10, 2009
By:
/s/ Bruce J. Haber  
    Name: Bruce J. Haber   
    Title: Chairman and Chief Executive Officer  
       

     
       
Date: November 10, 2009
By:
/s/ William M. McKay  
    Name: William M. McKay   
    Title: Chief Financial Officer and Secretary   
       
 
 
 
 
19